Literature DB >> 28725911

Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific.

Ilaria Marzinotto1, Daniela Liberati2, Cristina Brigatti1, Riccardo Bonfanti3, Angela Stabilini1, Paolo Monti1, Emanuele Bosi1,4, Lorenzo Piemonti1,4, Vito Lampasona5.   

Abstract

Entities:  

Keywords:  Autoantibodies; Autoimmunity; ELISA; IL-2; Immunoprecipitation; LIPS; Type 1 diabetes

Mesh：

Substances：

Year:  2017        PMID： 28725911     DOI： 10.1007/s00125-017-4376-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

Review 1.  Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays.

Authors:  Edwin Liu; George S Eisenbarth
Journal:  Clin Immunol       Date:  2007-09-27       Impact factor: 3.969

Review 2.  Anticytokine autoantibody-associated immunodeficiency.

Authors:  Sarah K Browne
Journal:  Annu Rev Immunol       Date:  2014-02-05       Impact factor: 28.527

3.  Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen.

Authors:  V Lampasona; M Ferrari; E Bosi; M R Pastore; P J Bingley; E Bonifacio
Journal:  J Autoimmun       Date:  1994-10       Impact factor: 7.094

4.  Loss of immune tolerance to IL-2 in type 1 diabetes.

Authors:  Louis Pérol; John M Lindner; Pamela Caudana; Nicolas Gonzalo Nunez; Audrey Baeyens; Andrea Valle; Christine Sedlik; Delphine Loirat; Olivier Boyer; Alain Créange; José Laurent Cohen; Ute Christine Rogner; Jun Yamanouchi; Martine Marchant; Xavier Charles Leber; Meike Scharenberg; Marie-Claude Gagnerault; Roberto Mallone; Manuela Battaglia; Pere Santamaria; Agnès Hartemann; Elisabetta Traggiai; Eliane Piaggio
Journal:  Nat Commun       Date:  2016-10-06       Impact factor: 14.919

5.  A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2.

Authors:  Peter D Burbelo; Hiroki Hirai; Hannah Leahy; Ake Lernmark; Sten A Ivarsson; Michael J Iadarola; Abner Louis Notkins
Journal:  Diabetes Care       Date:  2008-06-05       Impact factor: 19.112
  5 in total
  3 in total

1.  IL-2 antibodies in type 1 diabetes and during IL-2 therapy.

Authors:  Guillaume Churlaud; Michelle Rosenzwajg; Patrice Cacoub; David Saadoun; Dominique Valteau-Couanet; Nathalie Chaput; Alberto Pugliese; David Klatzmann
Journal:  Diabetologia       Date:  2018-06-02       Impact factor: 10.122

Review 2.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

3.  COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain.

Authors:  Massimiliano Secchi; Elena Bazzigaluppi; Cristina Brigatti; Ilaria Marzinotto; Cristina Tresoldi; Patrizia Rovere-Querini; Andrea Poli; Antonella Castagna; Gabriella Scarlatti; Alberto Zangrillo; Fabio Ciceri; Lorenzo Piemonti; Vito Lampasona
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.